ArticlePDF AvailableLiterature Review

Sulforaphane in broccoli: The green chemoprevention!! Role in cancer prevention and therapy

Authors:
  • Dental College, Regional Institute of Medical Sciences, Imphal, Manipur

Abstract

Isothicyanates present in cruciferous vegetables are known to exhibit chemoprevention by various mechanisms. Presently, there is growing evidence that a phytochemical compound known as sulforaphane in these green leafy vegetables is found to be effective in preventing and treating various cancers such as prostate cancer, breast cancer, colon cancer, skin, urinary bladder and oral cancers. This component is naturally present in the broccoli sprouts, kale, cabbage, cauliflower and garden cress and is available as a commercial supplementary pill called Broccoli extract. Availability of many bioactive substances such as vitamins, polyphenols, sulfides, glucosinolates and antioxidants makes broccoli consumption important in daily diet regularly. Researchers have named it as “Green chemoprevention.” It is easily affordable and more cost‑effective than the traditional chemopreventive drugs. Results from the epidemiological and experimental studies have emphasized the role of sulforophane as a complementary or alternative chemopreventive agent.
© 2020 Journal of Oral and Maxillofacial Pathology | Published by Wolters Kluwer - Medknow
Sulforaphane in broccoli: The green chemoprevention!! Role
in cancer prevention and therapy
D. B. Nandini1, Roopa S. Rao2, B. S. Deepak3, Praveen B. Reddy4
Departments of 1Oral Pathology and Microbiology, 3Conservave Denstry and 4Oral and Maxillofacial Surgery, Dental College, Regional
Instute of Medical Sciences, Imphal, Manipur, 2Department of Oral Pathology and Microbiology, M. S. Ramaiah Dental College,
Bengaluru, Karnataka, India
Review Article
INTRODUCTION
The value of cruciferous vegetables in cancer prevention
is being evaluated widely in the recent years. Fahey et al. in
1997 were the rst to introduce the anticarcinogenic property
of Broccoli sprouts (BSp).[1] Ever since, numerous studies
have shown that young broccoli and its sprouts provide
glucosinolates which have a preventive role in different primary
cancers as well as second tumors which are usually fatal.[2]
Broccoli contains many active biochemical substances
such as carotenoids, Vitamin C and glucosinates.
One such compound is sulforaphane (SFN)
(1‑isothiocyanato‑4‑[methylsulfinyl] butane), which
is derived from a precursor compound known as
glucoraphanin (GPN).[3] Conversion of GPN to SFN
occurs while cutting or chewing broccoli, which exposes the
GPN to the action of the endogenous myrosinase enzyme.
GPN is stable than SFN. GPN is several times more in
sprouts compared to the mature whole heads. In order to
exert physiologic activity, glucosinolates must be converted
to their bioactive form, known as isothiocyanates, by the
heat‑labile enzyme myrosinase.[4] However, this enzyme is
destroyed on cooking or even steaming or blanching for
Isothicyanates present in cruciferous vegetables are known to exhibit chemoprevention by various
mechanisms. Presently, there is growing evidence that a phytochemical compound known as sulforaphane
in these green leafy vegetables is found to be effective in preventing and treating various cancers such
as prostate cancer, breast cancer, colon cancer, skin, urinary bladder and oral cancers. This component is
naturally present in the broccoli sprouts, kale, cabbage, cauliflower and garden cress and is available as a
commercial supplementary pill called Broccoli extract. Availability of many bioactive substances such as
vitamins, polyphenols, sulfides, glucosinolates and antioxidants makes broccoli consumption important in
daily diet regularly. Researchers have named it as “Green chemoprevention.” It is easily affordable and more
cost-effective than the traditional chemopreventive drugs. Results from the epidemiological and experimental
studies have emphasized the role of sulforophane as a complementary or alternative chemopreventive agent.
Keywords: Adjuvant therapy, anticarcinogenic, antioxidant, antitumor, apoptosis, benefits, broccoli, cell
cycle, chemoprevention, effects, glucosinates, isothiocyanates, nutraceuticals myrosinase, sulforaphane
Abstract
Address for correspondence: Dr. D. B. Nandini, Department of Oral Pathology and Microbiology, Dental College, Regional Instute of Medical Sciences,
Imphal, Manipur, India.
E‑mail: nanni29@redimail.com
Submied: 22‑Apr‑2019, Revised: 06‑Sep‑2019, Accepted: 05‑Mar‑2020, Published: 09‑Sep‑2020
Access this article online
Quick Response Code:
Website:
www.jomfp.in
DOI:
10.4103/jomfp.JOMFP_126_19
How to cite this article: Nandini DB, Rao RS, Deepak BS, Reddy PB.
Sulforaphane in broccoli: The green chemoprevention!! Role in cancer
prevention and therapy. J Oral Maxillofac Pathol 2020;24:405.
This is an open access journal, and arcles are distributed under the terms of the Creave
Commons Aribuon‑NonCommercial‑ShareAlike 4.0 License, which allows others to remix,
tweak, and build upon the work non‑commercially, as long as appropriate credit is given and
the new creaons are licensed under the idencal terms.
For reprints contact: reprints@medknow.com
[Downloaded free from http://www.jomfp.in on Friday, September 11, 2020, IP: 117.230.190.138]
Nandini, et al.: Sulforaphane in broccoli
Journal of Oral and Maxillofacial Pathology | Volume 24 | Issue 2 | May-August 2020
more than a minute. It is further believed that boiling the
broccoli as well as thawing it below −85°C will spoil its
anticancer properties.[5]
SFN is one of the powerful anticarcinogenic substances
which work by increasing the levels of enzymes in
the liver, which counteract the carcinogenic effects of
chemicals in the food and environment. SFN is linked to
a sugar molecule through a sulfur band which needs to
be broken to release it. Then, a sulfur‑grabbing protein
will remove the exposed sulfur on SFN and inactivate
it. The myrosinase enzyme in the broccoli breaks this
bond. When broccoli is cut or chopped, the myrosinase
enzyme hydrolyzes SFN to form isothiocyanates.[6] SFN
production may reduce due to inactivation of myrosinase
enzyme. Isothiocyanate formation not only depends on
myrosinase but also on epithiospecier protein which helps
in the conversion of hydrolysis products to nitriles at the
expense of isothiocyanates. This protein is temperature
dependent and is known to get destroyed when broccoli
is heated at 60°C–70°C for 5–10 min. In such a condition,
the formation of SFN increases by 3–7 times.[7]
Raw or freshly harvested broccoli should be used whenever
possible. A delay of 10 days might result in loss of GPN
by nearly 80%.[8] Glucosinolates leak out in water while
boiling as they are water soluble. Hence, mild steaming
and microwaving may retain maximum SFN rather than
boiling.[6]
Unlike raw sprouts, many commercially available
supplements do not contain myrosinase, and this cannot
be encapsulated because it is active only when it is fresh.[5]
Consumption of broccoli along with a food ingredient
consisting of myrosinase enzyme provides more amount
of SFN. Mustard seed powder, daikon radish, wasabis,
arugula or coleslaws are some myrosinase‑rich food.
Some myrosinase enzyme is synthesized by the intestinal
bacteria which may not be seen in persons with imbalanced
ora. Myrosinase produced by the microorganisms in the
intestine further acts on the ingested glucosinolates which
have escaped the endogenous myrosinase in the plant.
However, mammalian cells lack this enzyme.[9] Iberin and
erucin are other compounds found in lesser amount in
broccoli extracts, which show similar cancer‑protective
property as SFN.[10]
BIOAVAILABILITY
Once SFN is ingested, it is primarily absorbed in jejunum
and enters circulation by passive diffusion.[11] SFN binds to
thiols of plasma proteins and crosses the plasma membrane
to enter the cells where it reacts with glutathione to form
conjugates which are expelled by the transporter protein
and metabolized to mercapturic acid. These metabolites are
transported to kidney where they are eliminated through
urine. It is observed that the urinary levels correlate with the
dietary consumption and serve as biomarkers.[12,13] SFN is
rapidly absorbed, reaching peak concentration after 1–3 h.
Levels are back to baseline within 72 h. The bioavailability is
said to be 74%. SFN tissue concentration varies depending
on the end organ. For example, SFN concentration in
the skin is less compared to those in plasma due to low
perfusion. Thus, dosage required may be more. Three doses
of 50–200 µmol daily are well tolerated.[14,15]
The amount of SFN varies in different plants of same
species and even in specic parts of the same plant. It also
depends on the cultivation, climate and other agronomic
factors.[11] Broccoli sprouts are said to be 20–50 times more
effective in chemoprevention than the mature heads. First,
sprouts contain more amount of GPN, a potent Phase 2
enzyme inducer and second, they cause less potential toxicity
due to minimal content of indole and b‑hydroxyalkenyl
glucosinolates.[16] Sulforadex or broccomax is a commercially
available synthetic form of SFN.[8]
Presence of myrosinase enzyme, epithiospecier protein,
and preparation of SFN are some other factors which
alter the bioavailability and pharmacokinetics of SFN. The
metabolites of SFN are removed through urine rapidly,
thereby enhancing the elimination of harmful carcinogens.
This process may, however, depend on individual genetic
variation in metabolism and excretion. Cooking methods
using less water such as steaming or microwaving also
increase the bioavailability of SFN. However, boiling,
microwaving at high power (>750 W) and steaming at
high temperature reduce the amount of SFN levels by
inactivating myrosinase enzyme.[16,17]
ROLE OF SULFORAPHANE IN VARIOUS
CANCERS AND EPIGENETIC ALTERATIONS
SFN has numerous cancer‑preventive properties [Table 1].
SFN role has been described in brief and requires a separate
extensive review by itself as there are numerous studies. It
promotes programmed cell death/apoptosis, induces cell
cycle arrest, inhibits angiogenesis, reduces inammation,
alters susceptibility to carcinogens, reduces invasion and
metastasis and exhibits antioxidant and anti‑inammatory
properties.[18] Evidence also suggests that SFN may target
the epigenetic alterations observed in specic cancers,
reversing aberrant changes in gene transcription through
mechanisms of histone deacetylase inhibition, global
[Downloaded free from http://www.jomfp.in on Friday, September 11, 2020, IP: 117.230.190.138]
Nandini, et al.: Sulforaphane in broccoli
Journal of Oral and Maxillofacial Pathology | Volume 24 | Issue 2 | May-August 2020
demethylation and microRNA modulation.[19] The role of
cruciferous vegetables in altering genetic expressions via
epigenetic modulation is being widely explored.
Carcinogenesis and cancer progression involve the genetic
and epigenetic changes in genome leading to transcriptional
dysregulation. Epigenetic alterations cause inhibition of the
tumor suppressor genes and promotion of the oncogenes,
leading to cancer development. Epigenetic mechanisms
include posttranslation histone modifications, DNA
global hypomethylation, noncoding RNAs and chromatin
remodeling. Genetic mutations are not reversible, but
epigenetic alterations are potentially reversible, making
them attractive targets for cancer chemoprevention.[19‑21]
The role of SFN in epigenetic modulation has been widely
explored in various cancers. SFN may be involved directly
or indirectly in effective upregulation of transcriptional
activity of certain genes and restoring the epigenetic
alterations. SFN and broccoli sprouts are considered as an
“epigenetics diet” and have shown to modify the epigenetic
pathways by targeting the histone deacetylases (HDAC)
and DNA methyltransferases (DNMT), thereby altering
the gene transcription and expression in cancer. SFN and
sprouts seem to alter the mitochondrial function and reduce
the lipid peroxidation. SFN could reverse the aberrant
epigenetic markers.[22]
Meeran et al. rst observed the signicant inhibition
of DNMT1 and DNMT3a expression by SFN in a
dose‑dependent manner in human breast cancer cells (MCF‑7
and MDA‑MB‑231 cell lines), and to a lesser extent in normal
MCF10A cells. SFN caused signicant downregulation of
human telomerase reverse transcriptase (hTERT) in breast
cancer cells, leading to apoptosis of cancer cells.[23]
Li et al. observed that SFN is a potent HDAC inhibitor,
which suppresses the hTERT, thereby causing the
reactivation of estrogen receptors (ERs) in the ER‑negative
breast cancer cells via epigenetic modulation. Maternal
and early postnatal intake of SFN and broccoli sprouts
was found to be benecial in preventing breast cancer at a
Table 1: Anticancer effects of sulforaphane
Anticancer effects Action of SFN
Induction of cell cycle arrest (S and G2/M) Increases cyclin 2, chk 2, p21
Inhibits cyclin B1, cdk1, cdc25B, cdc2
Reduction in cell proliferation Inhibits Phase 1 enzymes such as the CYP p450 family
Induces Phase 2 enzymes
Induction in apoptosis SFN induces pro‑apoptotic pathway and inhibits anti‑apoptotic pathways, Induces mitochondrial
apoptotic pathway
Increases Bax, induces p21 and p53
Activates Caspases 3, 7, 8 and 9
Reduces Bcl‑2 and Bcl‑XL
Inactivates PARP, decreases HIF1A and β‑catenin
Causes tubulin modulation, induces reactive oxygen species
Causes autophagy in cancer cells
Inhibition of tumor invasion, angiogenesis and
anti‑inflammatory effect
Inhibits NF‑κB pathway, activates Nrf‑2
Regulates MAPK
Inhibits TNF‑α, NLRP3, IL‑1β, IL‑18, IFN‑γ, IL6, IL‑17, IL‑23 and IL‑12, TGF‑β/Smad
Increases IL‑10, IL‑4, Arg1 and YM‑1 (R)
Inhibits NO, iNOS and COX‑2, silences Th17/Th1
Inhibits MMP‑9, LDH and PGE2
ROS, free radicals
Inhibits VEGF, Akt, EGF, CSF
Epigenetic modulation and altered gene
expression through histone deacetylase inhibition,
global demethylation and microRNA modulation
The Keap1/Nrf2 antioxidant pathway modulation
Histone acetyltransferase inhibition ‑ HDAC1, 2, 3 and 4 inhibition, decreases miR‑21 and hTERT
and inhibits DNMT 1 and 3A
Challenges pro‑oncogenic epigenetic pattern
Antimicrobial effects Increases human β defensins 2
Antioxidant effects
Reduction of susceptibility to carcinogens
Induction of the Keap1/Nrf2/ARE pathway related with antioxidant genes and detoxifying
enzymes, such as glutathione S‑transferases
Inhibits Phase 1 enzymes CYP1A1, A2, B1, CYP2B2, CYP3A4
Induces Phase 2 enzymes NQO1, GSTA1, HO ‑1, thereby reducing oxidative stress and DNA damage
Clears DNA‑damaging chemicals, reducing the toxicity on normal cells
SFN: Sulforaphane, PARP: Poly (ADP‑ribose) polymerase, HIF1A: Hypoxia‑inducible factor 1A, NF‑κB: Nuclear factor‑kappa B, Nrf‑2: Nuclear factor
erythroid‑2‑related factor 2, MAPK: Mitogen‑activated protein kinase, TNF‑α: Tumor necrosis factor‑alpha, IL: Interleukin, IFN‑γ: Interferon‑gamma,
TGF‑β: Transforming growth factor‑β, NO: Nitric oxide, iNOS: Inducible NO synthase, COX: Cyclooxygenase, MMP: Matrix metalloproteinase,
LDH: Lactate dehydrogenase, PGE2: Prostaglandin E2, ROS: Reactive oxygen species, VEGF: Vascular endothelial growth factor, EGF: Epidermal
growth factor, CSF: Colony stimulating factor, HDAC: Histone deacetylases, miR: MicroRNA, hTERT: Human telomerase reverse transcriptase,
DNMT: DNA methyltransferases, CYP: Cytochrome P450, NQO: Nitroquinoline‑1‑oxide, GSTA: Glutathione‑s‑transferase, NLRP3: Nucleotide‑
binding domain (NOD)‑like receptor protein 3, YM: A macrophage protein, a novel mammalian lectin
[Downloaded free from http://www.jomfp.in on Friday, September 11, 2020, IP: 117.230.190.138]
Nandini, et al.: Sulforaphane in broccoli
Journal of Oral and Maxillofacial Pathology | Volume 24 | Issue 2 | May-August 2020
later life by altering the tumor‑related gene expressions of
TERT, c‑Myc, p16 and p53 as observed by the authors.[24,25]
Atwell et al. have reviewed various preclinical and clinical
studies demonstrating the epigenetic alterations of SFN
in breast and prostate cancer and the role of SFN in the
regulation of cell cycle, apoptosis, inammation, antioxidant
defense and cancer cell signaling and their relationships
with epigenetic mechanism.[20] Kaufman‑Szymczyk et al.
suggested that SFN downregulates histone deacetylase
activity and subsequent alterations in gene promoter
methylation indirectly.[21]
Inhibition of hTERT in MCF‑7 and MDA‑MB‑231 breast
cancer cells and reduction in DNMT1 and DNMT3a by SFN
treatment were observed. SFN caused CpG demethylation
of hTERT. SFN treatment showed chromatin remodeling
with increase in chromatin markers such as H3K9ac and
acetyl‑H4 and decrease in H3K9me3 and H3K27me3 in
hTERT promoter. These changes resulted in the death of
breast cancer cells.[26] SFN caused downregulation of cyclin
D1, CDK4 and pRB and alterations in the levels of DNMT
and HDAC that resulted in the apoptosis of cancer cells.
SFN reduced DNMT expression and repressed methylation
silenced cyclin D2 expression in prostate cancer.[27]
Researchers found that SFN could affect a histone
methylation and could alter gene expression. SUV39H1, an
enzyme in prostate cancer cells, is affected by the exposure
to SFN, thereby suggesting this enzyme as a therapeutic
target. SFN has been proved effective in treating
advanced cancers as well as preventing the metastasis in
combination with the existing conventional therapies. It
helps in re‑expression of tumor suppressor genes, thereby
causing selective killing of cancer cells and reducing cancer
progression. Clinical human trials to prove the beneciary
effects of SFN are widely explored.[28]
SFN targets apoptosis at different steps, including
downregulation of anti‑apoptotic factors Bcl‑2 and
Bcl‑XL, upregulation of proapoptotic Bax, proteolytic
activation of caspase‑3 and degradation and/or cleavage
of poly(ADP‑ribose) polymerase.[29]
SFN induced apoptosis of the human leukemic cells KG1a
and K562 in a dose‑ and time‑dependent manner through
upregulation of Bax and Caspase‑3 and downregulation of
Bcl‑2. SFN exhibited anticancer effects on acute myeloid
leukemic cells as observed by Wang et al.[30]
SF was shown to modulate STAT3 in cancer cells and
prevent ultraviolet (UV) light‑induced skin cancer and
melanoma.[15] SFN causes epigenetic reactivation of Nrf2,
thereby downstreaming target genes HO‑1, NAD(P)
H:Quinone oxidoreductase 1 (NQO1) and UGT1A1 in a
mouse skin tumor model.[24]
SFN could increase mRNA and protein expressions of
Nrf2, and it downstreams target gene NQO1 by reducing
DNMT1 and DNMT3a. SFN also upregulates HDACs
1, 4, 5 and 7 and increases the level of active chromatin
marker acetyl‑histone 3(Ac‑H3) during tumorigenesis in vivo
(using TRAMP mice) and in vitro (using TRAMP C1 cells).
SFN thus downstreams antioxidative stress pathway partly
via epigenetic modications, and via expression of the
Nrf2 gene.[31]
SFN is a potent inducer of detoxication pathways by
promoting antioxidant glutathione. It leads to the inhibition
of Phase 1 enzymes such as cytochrome 450 that are
responsible for cell proliferation and tumor growth.
SFN induces Phase 2 enzymes by various mechanisms,
thereby removing the DNA‑damaging chemicals. Nuclear
factor erythroid‑2 (NF‑E2‑)‑related factor 2 (Nrf2) and
mitogen‑activated protein kinase (MAPK) are controlled
by SFN. On the other hand, an overexpression of Nrf‑2
makes cancer cells resistant to few chemotherapeutic drugs
as observed by Xu et al.[32] The authors suggested that the
time and the dose of SFN regulating this pathway during
the cancer therapy need further research. This will eliminate
the possible side effects while utilizing the anticancer effects
of SFN. SFN enhances the effect of the chemotherapeutic
agents by smaller doses and limits the toxicity to healthy
normal cells.[32]
Researchers found that persons consuming broccoli
regularly though not daily, expressed higher levels of tumor
suppressor gene p16 than those who had no or few of
these vegetables in their diet. This was surprising because
SFN is cleared of the body within 24 h. This suggests that
the SFN and its metabolites trigger epigenetic mechanisms
in the body, which enhances protection from cancer even
when the substance is eliminated from the body.[33] SFN is
said to induce a protein called Nrf2 which in later stages
of development of cancer is believed to support the
tumor growth and cause plaque buildup in arteries. Thus,
a further investigation on the role of Nrf2 in cancer and
cardiovascular disease is needed.
SFN has shown to induce apoptosis in colon cancer,
prostate cancer, breast cancer, liver cancer and lung cancer
in mice. Although the benets of SFN are proved in
cell‑based, animal and some human trials, recommendations
are few. Hence, at present, SFN use is limited as an adjuvant
[Downloaded free from http://www.jomfp.in on Friday, September 11, 2020, IP: 117.230.190.138]
Nandini, et al.: Sulforaphane in broccoli
Journal of Oral and Maxillofacial Pathology | Volume 24 | Issue 2 | May-August 2020
to the conventional chemotherapy and radiotherapy.
It may be helpful in preventing recurrence among
head‑and‑neck cancer survivors. Sulphoraphane helps
in protecting against chronic exposure to environmental
pollutants and carcinogens. Bauman et al. performed
studies involving mice as well as humans and found some
adverse effects on the use of this substance.[34] SFN is
believed to cause autophagy in cancer cells. Treatment
of prostate cancer cell lines, PC‑3 and LNCap, with SFN
resulted in the upregulation, processing and recruitment
to autophagosomes of microtubule‑associated protein
light chain 3.[35]
The nuclear factor‑kappa B (NF‑κB) prevents tumor
growth by inhibiting proliferation, angiogenesis and
invasion. Inflammation is known to induce tumor
proliferation and reduce apoptosis, thereby increasing
the risk of tumor development. SFN is said to reduce the
secretion of inammatory cytokines from blood cells,
thereby preventing the action of NF‑κB on DNA.[36]
Unlike normal cells, cancer cells evade the DNA repair
mechanisms and rapidly divide propagating the defective
mutations, and they do not respond to the apoptotic cell
signals. Broccoli extracts trigger the apoptosis of cancer
cells activated by the mitochondria and also cause the
arrest of cell division in S and M phases, which was
not specic to any cell and tissue. This resulted in a
decrease in cell division cycle 25C and breakdown of
mitotic spindle assemblies. SFN is said to inhibit tubulin
polymerization.[37]
The activation of the MAPK/ERK pathway has been
reported after SFN treatment in a number of cell lines,
including PC3 cells, through the activation of the activator
protein‑1 (AP‑1) transcription factor which plays a role in
apoptosis.[38]
Tang et al. also showed that broccoli extracts had the
ability to prevent cancer cell proliferation, which was
attributed to the presence of these isothiocyanates.[9]
Further, SFN in broccoli induced the formation of Phase
2 enzymes. Broccoli extracts revealed antiproliferative
properties similar to SFN, suggesting that they can be
used as a replacement for SFN for potential clinical test
and use. Thus, the naturally available SFN rather than
the pharmaceutical agent would be easily available, and
involves less complex procedures of preparation, thereby
being much cheaper and cost‑effective. However, loss of
SFN while eating sprouts may result due to epithiospecier
protein. Further research to maintain the stability of these
extracts is needed.[9]
Angiogenesis is an important step in carcinogenesis,
which supports the rapidly dividing cancer cells. SFN is
said to inhibit the development of new blood vessels,
thereby depriving the tumor cells and limiting the tumor
growth. In addition, SFN prevents tumor invasion and
metastasis. SFN can prevent the development and growth
of hormone‑sensitive tumors such as breast and prostate
cancers.[6] Glucosinolate hydrolysis promotes the apoptosis
of cultured prostate cancer cell lines, thereby inhibiting the
growth of tumor. An inverse association between intake of
cruciferous vegetables and the risk of developing prostate
cancer was suggested.[39]
Cancer stem cells (CSCs) initiate and maintain the
cancer and are also responsible for recurrence and drug
resistance, which is prevented by SFN.[40] Li et al., 2017,
observed that SFN reduced the proliferation rate of
oral squamous cell carcinoma CSCs in a dose‑dependent
manner.[41] In addition, they noticed a limited effect on
the normal oral mucosal cell proliferation. CSCs of oral
cancer showed reduced migration, invasion, clonogenicity,
in vivo tumorigenicity and a dose‑dependent increase in
the level of tumor‑suppressive miR200c, suggesting that
SFN suppressed initiation and stemness in cancer CSCs.
This led to a decrease in tumor growth and prevented
new tumor development as observed both in in vitro
and in vivo animal experiments. SFN possibly targets
the CSCs in various cancers via alteration of NF‑κB,
epithelial–mesenchymal transition and Wnt/β‑catenin
pathways.[40] Researchers believed that SFN when used
as an adjuvant along with conventional chemotherapy
yielded better results.[41]
The assessment of SFN in the regulation of miRNA
expression is limited in the literature, and further
investigation is required in order to complete understanding.
The upregulation of miR‑23b and miR‑27b in colorectal
cancer cells was signicant by SFN.[42]
HPV‑induced cervical cancer and Helicobacter pylori‑induced
gastric cancer are established facts. SFN was effective in
preventing these cancers. SFN was found to be effective
in reducing the conversion of intraepithelial neoplasia into
cervical cancer in mice.[43] Further, SFN in puried form
was found to be effective in the eradication of the strain
in both mice and human trials.[44] The ability of SFN to
modulate toll‑like receptor (TLR) activation and signaling
has been implicated as an additional chemopreventive
property. Zhu et al. observed that SFN caused inhibition
of TLR3, with the ability to modulate NFjB signaling and
downstream gene expression, including the downregulation
of interleukin 8 and tumor necrosis factor‑alpha.[45]
[Downloaded free from http://www.jomfp.in on Friday, September 11, 2020, IP: 117.230.190.138]
Nandini, et al.: Sulforaphane in broccoli
Journal of Oral and Maxillofacial Pathology | Volume 24 | Issue 2 | May-August 2020
Studies on single urinary bladder cancer cell
lines (UM‑UC‑3 cells) have revealed that isothionyates
in broccoli extracts along with SFN possess certain
antiproliferative properties inhibiting the tumor growth.
The authors believed that this may possibly be observed
in other types of cancer as well. The risk of urothelial and
bladder cancers was signicantly more in individuals who
carried genetic variants of glutathione S‑transferase (GST)
or NQO1 that yielded either a null or a suboptimal
phenotype. This is not surprising, because both these
Phase 2 enzymes are important cellular protectants
against carcinogens and oxidants.[46] The ability of SFN
to sensitize drug‑resistant cancer cells to TNF‑related
apoptosis‑inducing ligand (TRAIL)‑induced apoptosis
has been demonstrated in multiple studies, with reports
demonstrating SFN‑enhanced TRAIL‑induced apoptosis
in human hepatoma cells.[47]
Thus, various studies have shown that SFN induces
mitochondria‑mediated cellular apoptosis, induces cell
cycle arrest, acts as antioxidant reducing the oxidative
stress, induces Nrf‑2 preventing inflammation and
cytokine secretion, inhibits histone deacetylase and DNA
methylation thereby altering epigenetic mechanism and
induces Phase 2 enzymes such as GST and quinone
oxidoreductase 1, thereby protecting the cells from DNA
damage caused by carcinogens and reactive oxygen species,
disrupting the oncogenic signaling pathways.
OTHER HEALTH BENEFITS OF SULFORAPHANE
SFN has other benecial effects in addition to cancer
protection. SFN exhibits neuroprotective effects and is
implemented in treating conditions such as traumatic
brain injury, Alzheimer’s disease and Parkinson’s disease.
Patients with autism have shown an improvement in social
interaction, abnormal behavior and verbal communication
after treatment with these compounds. SFN contains a
avonoid kaempferol which is effective in treating various
allergies.[6] Broccoli has Vitamin A and higher amounts
of ber, which improves the digestion and gut health.
It lowers cholesterol and combats ulcer‑causing H. pylori
bacteria in the digestive system. Broccoli extracts are said
to prevent and repair the skin damage caused by UV light,
however results on animal and human showed variation.
High levels of carotenoids, lutein and zeaxanthin support
eye health.[48] SFN supports detoxication because it has
amino acids, Vitamin C and sulfur. Further, SFN shows
anti‑inammatory effects, thus preventing many chronic
diseases such as colitis, arthritis, airway‑related problems
such as asthma and chronic obstructive pulmonary
disease. It provides important vitamins and minerals,
including magnesium, potassium, calcium, protein and
Vitamin C, which improves the bone health, delays aging,
boosts immunity and promotes hair growth. It prevents
nonalcoholic fatty liver. It also helps in preventing the
thickening of the arteries, thereby reducing the risk for
heart disease. SFN is also said to reduce cholesterol levels.[34]
Broccoli has a low glycemic index as it contains both soluble
ber and chromium, which is benecial in diabetic patients
when consumed in moderate quantity.[17,49,50]
ADVERSE EFFECTS
SFN acts as a double‑edge sword. Eating broccoli in
moderate quantity is benecial, however excess consumption
might lead to some side effects. Excess consumption in
diabetic patients may give rise to hypoglycemia. Possible
liver toxicity on intake of extreme doses has also been
reported. Side effects such as gastric irritation, irritable
bowel syndrome, diarrhea, abdominal pain and atulence
due to its high ber content have also been reported.
Isothiocyanates in broccoli are said to be goitrogens which
alter the uptake of iodine, thereby altering the function of
thyroid gland, resulting in hypothyroidism.[6] Broccoli has
numerous traces of pesticides, of which formaldehyde is
carcinogenic. It may cause allergic reactions such as skin
rashes, itching, nasal congestion, wheezing and headache
in some people. Smokers who consume excess broccoli
may be at risk for developing lung cancer due to excess
antioxidants. Risk of hemorrhagic stroke in persons with
excess broccoli consumption is linked to Vitamin E in
broccoli. Intake of too much potassium‑rich broccoli can
lead to the risk of hypotension. Vitamin K in broccoli
might alter blood clotting and increase bleeding risk in
patients having blood thinners if intake is excess. Thus,
consumption in extreme doses has shown some side
effects.[49] However, the health benets outweigh the side
effects when consumed in right amount.
CONCLUSION
Broccoli and its sprouts contain naturally occurring
isothiocyanates such as SFN with potent cancer‑ghting
properties. In vitro and animal experiments have extensively
studied the role of SFN in treating different types of cancers
as well as other diseases. Although commercial supplements
are available, they are not Food and Drug Administration
approved as yet. In addition, the pharmacokinetics and
side effects are widely being explored at present. Further
clinical studies and human trials related to their safety, side
effects, isolation and therapeutic dosage and frequency of
intake would provide an insight into the benecial effects
of these isothiocyanates. They provide an easily available,
[Downloaded free from http://www.jomfp.in on Friday, September 11, 2020, IP: 117.230.190.138]
Nandini, et al.: Sulforaphane in broccoli
Journal of Oral and Maxillofacial Pathology | Volume 24 | Issue 2 | May-August 2020
cost‑effective alternative chemoprevention with little side
effects compared to the conventional chemotherapeutic
drugs. It is worthwhile to consume these vegetables in the
right amount on a regular basis to promote general health
and reduce the cancer risk.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conicts of interest.
REFERENCES
1. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: An exceptionally
rich source of inducers of enzymes that protect against chemical
carcinogens. Proc Natl Acad Sci U S A 1997;94:10367‑72.
2. Zhang Y. Cancer chemoprevention with sulforaphane, a dietary
isothiocyanate. In: Bao Y, Fenwick R, editors. Phytochemicals in Health
and Disease. New York: Marcel Dekker; 2004. p. 121‑41.
3. Zhang Y, Tang L. Discovery and development of sulforaphane
as a cancer chemopreventive phytochemical. Acta Pharmacol Sin
2007;28:1343‑54.
4. Bricker GV, Riedl KM, Ralston RA, Tober KL, Oberyszyn TM,
Schwartz SJ. Isothiocyanate metabolism, distribution, and interconversion
in mice following consumption of thermally processed broccoli sprouts
or puried sulforaphane. Mol Nutr Food Res 2014;58:1991‑2000.
5. Dosz EB, Jeffery EH. Commercially produced frozen broccoli lacks
ability to form sulforaphane. J Funct Foods 2013;5:987‑90.
6. Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous
vegetables and human cancer risk: Epidemiologic evidence and
mechanistic basis. Pharmacol Res 2007;55:224‑36.
7. Matusheski NV, Juvik JA, Jeffery EH. Heating decreases epithiospecier
protein activity and increases sulforaphane formation in broccoli.
Phytochemistry 2004;65:1273‑81.
8. Hoffman RL. Clinical Focus: The Cancer‑Preventive Properties of
Sulforaphane; 2017. Available from: http//drhoffman.com. [Last
accessed on 2018 Nov 17].
9. Tang L, Zhang Y, Jobson HE, Li J, Stephenson KK, Wade KL, et al.
Potent activation of mitochondria‑mediated apoptosis and arrest in S
and M phases of cancer cells by a broccoli sprout extract. Mol Cancer
Ther 2006;5:935‑44.
10. Wang W, Wang S, Howie AF, Beckett GJ, Mithen R, Bao Y. Sulforaphane,
erucin, and iberin up‑regulate thioredoxin reductase 1 expression in
human MCF‑7 cells. J Agric Food Chem 2005;53:1417‑21.
11. Wu X, Zhou QH, Xu K. Are isothiocyanates potential anti‑cancer drugs?
Acta Pharmacol Sin 2009;30:501‑12.
12. Chung FL, Jiao D, Getahun SM, Yu MC. A urinary biomarker for uptake
of dietary isothiocyanates in humans. Cancer Epidemiol Biomarkers
Prev 1998;7:103‑8.
13. Mennicke WH, Kral T, Krumbiegel G, Rittmann N. Determination of
N‑acetyl‑S‑(N‑alkylthiocarbamoyl)‑L‑cysteine, a principal metabolite of
alkyl isothiocyanates, in rat urine. J Chromatogr Biomed 1987;414:19‑24.
14. Dinkova‑Kostova AT, Jenkins SN, Fahey JW, Ye L, Wehage SL, Liby KT,
et al. Protection against UV‑light‑induced skin carcinogenesis in SKH‑1
high‑risk mice by sulforaphane‑containing broccoli sprout extracts.
Cancer Lett 2006;240:243‑52.
15. Tahata S, Singh SV, Lin Y, Hahm ER, Beumer JH, Christner SM, et al.
Evaluation of biodistribution of sulforaphane after administration of
oral broccoli sprout extract in melanoma patients with multiple atypical
nevi. Cancer Prev Res (Phila) 2018;11:429‑38.
16. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P.
Chemoprotective glucosinolates and isothiocyanates of broccoli
sprouts: Metabolism and excretion in humans. Cancer Epidemiol
Biomarkers Prev 2001;10:501‑8.
17. Anubhuti Sh, Ashok Sh, Prashant Y, Dhiraj S. Isothiocyanates in
Brassica: Potential anti cancer agents. Asian Pac J Cancer Prev
2016;17:4507‑10.
18. Zhang Y, Tang L, Gonzalez V. Selected isothiocyanates rapidly induce
growth inhibition of cancer cells. Mol Cancer Ther 2003;2:1045‑52.
19. Vaiopoulos AG, Athanasoula KCh, Papavassiliou AG. Epigenetic
modications in colorectal cancer: Molecular insights and therapeutic
challenges. Biochim Biophys Acta 2014;1842:971‑80.
20. Atwell LL, Hsu A, Wong CP, Stevens JF, Bella D, Yu TW, et al. Absorption
and chemopreventive targets of sulforaphane in humans following
consumption of broccoli sprouts or a myrosinase‑treated broccoli
sprout extract. Mol Nutr Food Res 2015;59:424‑33.
21. Kaufman‑Szymczyk A, Majewski G, Lubecka‑Pietruszewska K,
Fabianowska‑Majewska K. The role of sulforaphane in epigenetic
mechanisms, including interdependence between histone modication
and DNA Methylation. Int J Mol Sci 2015;16:29732‑43.
22. Li Y, Zhang T. Targeting cancer stem cells with sulforaphane, a
dietary component from broccoli and broccoli sprouts. Future Oncol
2013;9:1097‑103.
23. Meeran SM, Patel SN, Tollefsbol TO. Sulforaphane causes epigenetic
repression of hTERT expression in human breast cancer cell lines.
PLoS One 2010;5:e11457.
24. Su ZY, Zhang C, Lee JH, Shu L, Wu TY, Khor TO, et al. Requirement and
epigenetics reprogramming of Nrf2 in suppression of tumor promoter
TPA‑induced mouse skin cell transformation by sulforaphane. Cancer
Prev Res (Phila) 2014;7:319‑29.
25. Su X, Jiang X, Meng L, Dong X, Shen Y, Xin Y. Anticancer
activity of sulforaphane: The epigenetic mechanisms and the
Nrf2 signaling pathway. Oxid Med Cell Longev 2018;438179. doi:
10.1155/2018/5438179.
26. Carlos‑Reyes Á, López‑González JS, Meneses‑Flores M,
Gallardo‑Rincón D, Ruíz‑García E, Marchat LA, et al. Dietary
compounds as epigenetic modulating agents in cancer. Front Genet
2019;10:79.
27. Royston KJ, Paul B, Nozell S, Rajbhandari R, Tollefsbol TO. Withaferin
A and sulforaphane regulate breast cancer cell cycle progression through
epigenetic mechanisms. Exp Cell Res 2018;368:67‑74.
28. Watson GW, Wickramasekara S, Palomera‑Sanchez Z, Black C,
Maier CS, Williams DE, et al. SUV39H1/H3K9me3 attenuates
sulforaphane‑induced apoptotic signaling in PC3 prostate cancer cells.
Oncogenesis 2014;3:e131.
29. Park SY, Kim GY, Bae SJ, Yoo YH, Choi YH. Induction of apoptosis
by isothiocyanate sulforaphane in human cervical carcinoma HeLa and
hepatocarcinoma HepG2 cells through activation of caspase‑3. Oncol
Rep 2007;18:181‑7.
30. Wang F, Chen L, Zhu S, Wang S, Chen C, Zhang W, et al. SFN induces
apoptosis of acute human leukemic cells through modulation of Bax,
Bcl‑2, Caspase‑3. Int J Pharmcol 2018;14:369‑76.
31. Zhang C, Su ZY, Khor TO, Shu L, Kong AN. Sulforaphane enhances
Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic
regulation. Biochem Pharmacol 2013;85:1398‑404.
32. Xu T, Ren D, Sun X, Yang G. Dual roles of sulforaphane in cancer
treatment. Anticancer Agents Med Chem 2012;12:1132‑42.
33. Rajendran P, Kidane AI, Yu TW, Dashwood WM, Bisson WH, Löhr CV,
et al. HDAC turnover, CtIP acetylation and dysregulated DNA damage
signaling in colon cancer cells treated with sulforaphane and related
dietary isothiocyanates. Epigenetics 2013;8:612‑23.
34. Bauman JE, Zang Y, Sen M, Li C, Wang L, Egner PA, et al. Prevention of
carcinogen‑induced oral cancer by sulforaphane. Cancer Prev Res (Phila)
2016;9:547‑57.
35. Herman‑Antosiewicz A, Johnson DE, Singh SV. Sulforaphane causes
autophagy to inhibit release of cytochrome C and apoptosis in human
prostate cancer cells. Cancer Res 2006;66:5828‑35.
36. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhäuser C. Nuclear
[Downloaded free from http://www.jomfp.in on Friday, September 11, 2020, IP: 117.230.190.138]
Nandini, et al.: Sulforaphane in broccoli
Journal of Oral and Maxillofacial Pathology | Volume 24 | Issue 2 | May-August 2020
factor kappa B is a molecular target for sulforaphane‑mediated
anti‑inammatory mechanisms. J Biol Chem 2001;276:32008‑15.
37. Jackson SJ, Singletary KW. Sulforaphane inhibits human MCF‑7
mammary cancer cell mitotic progression and tubulin polymerization.
J Nutr 2004;134:2229‑36.
38. Xu C, Yuan X, Pan Z, Shen G, Kim JH, Yu S, et al. Mechanism of action
of isothiocyanates: The induction of ARE‑regulated genes is associated
with activation of ERK and JNK and the phosphorylation and nuclear
translocation of Nrf2. Mol Cancer Ther 2006;5:1918‑26.
39. Beaver LM, Kuintzle R, Buchanan A, Wiley MW, Glasser ST,
Wong CP, et al. Long noncoding RNAs and sulforaphane: A target for
chemoprevention and suppression of prostate cancer. J Nutr Biochem
2017;42:72‑83.
40. Li Y, Buckhaults P, Li S, Tollefsbol T. Temporal Efficacy of a
Sulforaphane‑Based Broccoli Sprout Diet in Prevention of Breast
Cancer through Modulation of Epigenetic Mechanisms. Cancer Prev
Res (Phila) 2018;11:451‑64.
41. Liu CM, Peng CY, Liao YW, Lu MY, Tsai ML, Yeh JC, et al. Sulforaphane
targets cancer stemness and tumor initiating properties in oral squamous
cell carcinomas via miR‑200c induction. J Formos Med Assoc
2017;116:41‑8.
42. Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal
cancer: Translation of molecular biology into clinical application. Mol
Cancer 2009;8:102.
43. Galan MV, Kishan AA, Silverman AL. Oral broccoli sprouts for the
treatment of Helicobacter pylori infection: A preliminary report. Dig Dis
Sci 2004;49:1088‑90.
44. Stanley M. Chapter 17: Genital human papillomavirus infections‑‑current
and prospective therapies. J Natl Cancer Inst Monogr 2003;(31):117‑24.
45. Zhu J, Ghosh A, Coyle EM, Lee J, Hahm ER, Singh SV, et al. Differential
effects of phenethyl isothiocyanate and D, L‑sulforaphane on TLR3
signaling. J Immunol 2013;190:4400‑7.
46. Munday R, Mhawech‑Fauceglia P, Munday CM, Paonessa JD, Tang L,
Munday JS, et al. Inhibition of urinar y bladder carcinogenesis by broccoli
sprouts. Cancer Res 2008;68:1593‑600.
47. Kim H, Kim EH, Eom YW, Kim WH, Kwon TK, Lee SJ, et al.
Sulforaphane sensitizes tumor necrosis factor‑related apoptosis‑inducing
ligand (TRAIL)‑resistant hepatoma cells to TRAIL‑induced apoptosis
through reactive oxygen species‑mediated up‑regulation of DR5. Cancer
Res 2006;66:1740‑50.
48. Villarreal‑García D, Alanís‑Garza PA, Cuéllar‑Villarreal MR,
Redondo‑Gil M, Mora‑Nieves JL, Jacobo‑Velázquez DA. Effect of
different defrosting methods on the stability of bioactive compounds
and consumer acceptability of frozen broccoli. CyTA J Food
2013;13:312‑20.
49. Villarreal‑García D, AJacobo‑Velázquez D. Glucosinolates from
broccoli: Nutraceutical properties and their purication. Curr Trends
Nutraceuticals 2016;1:1‑6.
50. Live Science. Sulforaphane a Powerful Tool to Fight Cancer, Aging,
and Other Inammatory Health Issues; 2017. Available from: https://
alivebynature.com/sulforaphane‑and‑cancer/. [Last accessed on
2017 Aug 17].
[Downloaded free from http://www.jomfp.in on Friday, September 11, 2020, IP: 117.230.190.138]
... 56 Kaempferol in broccoli serves as a cure for allergies, and quercetin is a flavonoid with antioxidative action. 57 Table 2 summarizes the bioactive compounds in broccoli. ...
... profiles, helping to prevent cardiovascular diseases such as atherosclerosis, stroke, coronary artery disease, and myocardial infarction. 73 A review by Nandini et al. 57 highlighted the presence of sulforaphane and vitamin C in broccoli. This has the capacity to reduce cholesterol and provide protection from thickening of blood vessels, thus contributing to overall heart health. ...
... In addition to sulforaphane, trace amounts of compounds like iberin and erucin have also been reported to exhibit anticancer properties in this green vegetable. 57 Gaafar et al. 82 investigated the cytotoxic activity of brassica vegetable residues, preparing methanol extracts from broccoli leftovers and analyzing phenolics, flavonoids, and tannins using high-performance liquid chromatography. Broccoli residues showed higher values than cauliflower, Brussels sprouts, and radish, supporting their potential cancer-preventive properties. ...
Article
Full-text available
Broccoli (Brassica oleracea var. italica L.), a biennial cool‐season crop of the Brassicaceae family, originates from the Mediterranean region and is renowned for its exceptional nutritional qualities. Its increasing global popularity has been attributed to its bioactive compounds, particularly glucosinolates and their hydrolysis product, sulforaphane, which provide numerous health benefits. Sulforaphane demonstrates protective effects against metabolic diseases such as diabetes mellitus and severe conditions, including stroke, myocardial infarction, and cancer. Broccoli's low caloric and high fiber content makes it an ideal dietary component. Its by‐products, often considered inedible (stalks, stems, and leaves), also have various sustainable applications. These include prolonging shelf life, the development of agrochemicals, the creation of nanoparticles, and the formulation of functional foods, beverages, and medicines, all at reduced costs. This review highlights broccoli's health‐supporting attributes and phytochemical composition, emphasizing its potential as a functional crop. The study also explores the use of broccoli's postharvest residues in zero‐waste solutions, highlighting their potential as eco‐friendly alternatives with economic benefits for the food and agricultural industries. © 2025 Society of Chemical Industry.
... Broccoli is rich in vitamins A and C, thiamine, niacin, and riboflavin, as well as minerals like calcium and iron. It is also a rich source of sulphoraphane, a compound associated with reducing cancer risk (Nandini, 2020) [9] . Broccoli's market demand is increasing globally due to its nutritional value and multifarious uses (Rangkadilok et al., 2004) [13] . ...
... Broccoli is rich in vitamins A and C, thiamine, niacin, and riboflavin, as well as minerals like calcium and iron. It is also a rich source of sulphoraphane, a compound associated with reducing cancer risk (Nandini, 2020) [9] . Broccoli's market demand is increasing globally due to its nutritional value and multifarious uses (Rangkadilok et al., 2004) [13] . ...
Research
Full-text available
A field experiment was conducted during the winter season of 2019-20 to investigate the response of broccoli to different fertigation treatments. The experiment consisted of four irrigation levels (I1: 1.20 ETc, I2: 1.00 ETc, I3: 0.8 ETc, and I4: 0.6 ETc) and four fertilizer levels (F1: 100% recommended dose of NPK (RD), F2: 75% RD of NPK, F3: 50% RD of NPK, and F4: no fertilizer). The results showed that the treatment combination of I1F1 produced the highest head diameter (14.84 cm), head yield (225.41 g/plant), total yield (18.69 t/ha), harvest index (52.11%), protein content of head (30.03 mg/g), and starch content (55.73 µg/g). Conversely, the treatment combination of I4F4 resulted in the lowest values for these parameters, with head diameter (9.34 cm), head yield (71.41 g/plant), total yield (6.29 t/ha), harvest index (34.35%), protein content of head (19.49 mg/g), and starch content (31.19 µg/g). These findings suggest that optimized fertigation management can significantly improve broccoli yield and quality.
... They also activate detoxifying enzymes and reduce oxidative stress. Brassica vegetables should be consumed at least five times a week for adults to receive adequate and balanced nutrition [12][13][14]. ...
Article
Full-text available
Background There is no doubt that one of the most considerable researcher dilemmas is cancer. Radiofrequency-photodynamic therapy (RFPDT) offers novel approaches to cancer treatment by combining radiofrequency-dynamic therapy and photodynamic therapy with sensitizers. While novel sensitizers for RFPDT have been synthesized successfully, their effective application is still limited. Their limited ability to transfer sensitizer's deeper intratumorally, low tumor-targeting selectivity, and failing tumor microenvironment all restrict their anti-tumor activity. The goal of the current work was to examine the most recent advancement in activated cancer treatment using radiofrequency assisted drug delivery of conjugated activated carbon nanoparticles of broccoli, cabbage, and kale (BCK-ACNP) to treat colorectal cancer (CRCA) using both in vivo and in vitro RFPDT. Materials and methods The current study included human CRCA cells (SW-620) and Swiss albino induce CRCA mice [treated with 1,2-dimethylhydrazine (DMH) and dextran sulphate sodium (DSS) only] were used in the in vitro and in vivo study. The study treatment protocol started only after CRCA induction, and involved daily administration of BCK-ACNP as RFPDT sensitizer whether or not to be exposed to laser (IRL) or radiofrequency (RF) or a combination of them for 3 min for a period of 2 weeks. Results Demonstrated that ACNP is a useful BCK delivery mechanism that targets CRCA cells directly. Furthermore, BCK-ACNP is a promising RFPS that, when used in conjunction with RFPDT, can be very effective in in vitro treating CRCA-SW-620 (in a dose-dependent manner cell viability declined, an increase in the population of cells during the S and G2/M phases indicates that the cell cycle was arrested, and an increase in the Pre-G cell population, autophagic cell death, as well as early and late apoptosis and necrosis, indicate that cell death was induced) and DMH/DSS-CRCA-induced mice in vivo (induced antiproliferative genes, p53, Bax, TNFalpha, caspase 3,9, repressed antiangiogenic and antiapoptotic genes, VEGF and Bcl2 respectively), successfully slowing the growth of tumors and even killing cancer cells, as well as lowering oxidative stress (MDA), improving the functions of the kidneys (urea, creatinine), liver (ALT, AST), and antioxidants (GPx, GR, GST, GSH, CAT, SOD, TAC). RFPDT, the photochemical or radiofrequency BCK activation mechanism, and the antioxidant capacity of non-activated BCK can all be linked to this process. Conclusion Based on the findings, BCK-ACNP shows a great promise as a cutting-edge, efficient selective delivery system for localized RFPDT-activated colorectal cancer treatment.
... Another study examined the effect of sulforaphane, a naturally occurring substance often present in broccoli, 78 on the expression of HIF-1α in HCT116 (colon cancer) and AGS (gastric cancer) cells. Sulforaphane suppressed HIF-1α protein expression in HCT116 and AGS cells when exposed to low-oxygen conditions. ...
Article
Full-text available
Hypoxia-inducible factor (HIF)-1 is a transcription factor that regulates the expression of target genes associated with oxygen homeostasis under hypoxic conditions, thereby contributing to tumor development and progression. Accumulating evidence has demonstrated that HIF-1α mediates different biological processes, including tumor angiogenesis, metastasis, metabolism, and immune evasion. Thus, overexpression of HIF-1α is strongly associated with poor prognosis in cancer patients. Natural compounds are important sources of anticancer drugs and studies have emphasized the decisive role of these mediators in modulating HIF-1α. Therefore, the pharmacological targeting of HIF-1α has emerged as a novel cancer therapeutic approach in recent years. The novelty of this review is that it summarizes natural products targeting HIF-1α in colorectal cancer that have not been presented earlier. We studied research publications related to the HIF-1α domain in cancer from 2010 to 2024. However, our main focus was to identify a better targeted approach for colorectal carcinoma management. Our review described HIF-1α role in tumor progression, summarizes the natural compounds employed as HIF-1α inhibitors, and discusses their potential in the development of natural compounds as HIF-1α inhibitors for colorectal cancer treatment.
... It is rich in vitamins, minerals, and bioactive compounds, such as glucosinolates, phenolic compounds, and high dietary fibers [16]. Sulforaphane, a naturally occurring isothiocyanate derived from glucoraphanin in broccoli, has been extensively studied for its anticancer, antioxidant, and anti-inflammatory properties [17][18][19]. Additionally, recent studies have suggested that sulforaphane may possess antimicrobial activity against oral pathogens, including Streptococcus mutans, a primary causative agent of dental caries [20,21]. ...
Article
Full-text available
Background and Aims Dental caries remains highly prevalent among children. This study aimed to evaluate the efficacy of aqueous broccoli extract in enhancing the microhardness of demineralized primary tooth enamel compared to a standard fluoride treatment. Methods An in vitro study was conducted using 30 extracted primary second molars, which were sectioned and polished. Baseline enamel microhardness was assessed using a Vickers hardness tester. Demineralization was induced using a cola drink (pH 4.5) for 8 min. The broccoli extract was prepared by air‐drying fresh florets, stems, and leaves at room temperature, followed by aqueous extraction with distilled water and filtration. The samples were randomly assigned to receive a 10‐min treatment with either aqueous broccoli extract (Group B) or 1.23% acidulated phosphate fluoride (APF) gel (Group F). Microhardness was measured posttreatment, and percentage changes between time points were compared using statistical analysis. Results After demineralization, broccoli extract, and fluoride gel significantly improved enamel microhardness. The broccoli extract group exhibited a greater recovery in microhardness (+44.95% vs. +20.78%, p = 0.008) compared to the fluoride gel group. However, the overall reduction in microhardness from baseline to final measurement showed no statistically significant difference between the two groups (p = 0.077). Conclusion Aqueous broccoli extract demonstrated comparable overall efficacy to fluoride gel in enhancing demineralized primary tooth enamel microhardness despite showing different patterns of demineralization and recovery. These findings suggest that broccoli extract may be a natural and effective alternative for enhancing enamel remineralization in pediatric caries prevention, warranting further clinical investigation.
... On the other hand, sulforaphane has been thoroughly investigated for its chemopreventive properties by inhibiting histone deacetylases (HDAC), which play a critical role in tumor gene expression. [98][99][100] In light of the above, miRNAs from broccoli may play a role in the health benefits associated with consuming cruciferous vegetables. Consequently, broccoli-derived EVs were evaluated in vitro as effective carriers for miRNA transport and delivery, demonstrating the potential to produce biological effects on host cells. ...
Article
Full-text available
The pursuit of effective drug delivery systems is critical in advancing cancer therapies, particularly in the realms of chemotherapy, radiotherapy and immunotherapy. This review focuses on plant-based extracellular vesicles (PBEs) as innovative nanoplatforms for encapsulating and delivering genetic materials, including microRNAs (miRNAs), small interfering RNAs (siRNAs), and mitochondrial DNA (mtDNA). We explore the unique properties of PBEs that enhance the stability and bioavailability of these therapeutic molecules, particularly their resistance to degradation by ribonucleases (RNases) and their ability to withstand gastrointestinal digestion. By improving the stability and facilitating cellular uptake of these genetic particles, PBEs offer a significant enhancement of their therapeutic efficacy through nuclear gene modulation. This review highlights the transformative potential of PBEs in developing novel drug delivery systems for cancer treatment, paving the way for future research and clinical advancements in RNA-based therapies and beyond.
Article
The review emphasizes the medical advantages of phytoconstituents and the essential role of advanced analytical technologies in formulating effective treatments for colon diseases. Phytoconstituents, plant‐derived bioactive compounds, exhibit a range of therapeutic properties, including antimicrobial, antifungal, anticancer, antioxidant, anti‐inflammatory, and antidiabetic effects. Key phytoconstituents like alkaloids, phenolics, carotenoids, terpenoids, and organosulfur compounds play a crucial role in modulating inflammatory pathways, maintaining gut microbiota balance, and supporting intestinal health. To enable precise and simultaneous quantification of drugs and metabolites, the review highlights modern phytochemical analysis techniques such as high‐performance liquid chromatography (HPLC), UV chromatography, liquid chromatography (LC), gas chromatography (GC), and mass spectrometry (MS). It addresses various colonic diseases, including colonic polyps, diverticulitis, ulcerative colitis, and irritable bowel syndrome (IBS), which impact the large intestine. Despite advancements in medical infrastructure leading to improved management strategies, colon disorders continue to impose substantial financial, emotional, and physical burdens on patients. This review aims to analyze the potential of phytoconstituents in managing colon diseases, summarizing their pharmacological properties and mechanisms of action. It discusses the bioactive compounds from various plant sources, their effects on colon health, and the analytical methods used to identify and quantify these substances. Furthermore, it explores the challenges and future directions for utilizing phytoconstituents as therapeutic agents, emphasizing the need for clinical trials and evidence‐based research to validate their efficacy and safety. Overall, the review underscores the significance of phytoconstituents in addressing colon diseases and calls for further research to unlock their full therapeutic potential.
Article
Full-text available
Over the years, the global disease burden of neurological disorders (NDs) and mental disorders (MDs) has significantly increased, making them one of the most critical concerns and challenges to human health. In pursuit of novel therapies against MD and ND, there has been a growing focus on nutrition and health. Dietary sulfur, primarily derived from various natural sources, plays a crucial role in numerous physiological processes, including brain function. This review offers an overview of the chemical composition of several natural sources of the sulfur-rich substances such as isothiocyanates, sulforaphane, glutathione, taurine, sulfated polysaccharides, allyl sulfides, and sulfur-containing amino acids, all of which have neuroprotective properties. A multitude of studies have documented that consuming foods that are high in sulfur enhances brain function by improving cognitive parameters and reduces the severity of neuropathology by exhibiting antioxidant and anti-inflammatory properties at the molecular level. In addition, the growing role of natural sulfur compounds in repairing endothelial dysfunction, compromising blood–brain barrier and improving cerebral blood flow, are documented here. Furthermore, this review covers the encouraging results of supplementing sulfur-rich diets in many animal models and clinical investigations, along with their molecular targets in MD, such as schizophrenia, depression, anxiety, bipolar disorder, and autism spectrum disorder, and ND, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS). The prospects of natural sulfur compounds show great promise as they have potential applications in nutraceuticals, medicines, and functional foods to enhance brain function and prevent diseases. However, additional research is required to clarify the mechanisms by which it works, enhance its bioavailability, and evaluate its long-term safety for broad use.
Article
Full-text available
Background/Objectives: Oral squamous cell carcinoma (OSCC) is a significant global health concern, necessitating the development of novel treatment strategies. The present study investigated the in vitro anticancer activity of sulforaphane (SFN), an isothiocyanate derived from Brassica oleracea, on the OECM-1 human oral squamous carcinoma cell line. Methods: OECM-1 cells were cultured and exposed to a range of SFN concentrations. To assess the cell viability and determine the half maximal inhibitory concentration (IC50) of SFN following 24 h of treatment, an MTT assay was performed. Apoptosis was evaluated using AO/PI staining, a TUNEL assay, Annexin V-FITC analysis, and a DNA fragmentation assay. Changes in the mitochondrial membrane potential were analyzed using a JC-1 staining assay. A Western blot assay was performed to assess the expression levels of apoptosis-associated proteins (Bax, Bcl2, caspase-3, caspase-9, PARP, Smad-4, p53, cytochrome c, and GAPDH). Cell cycle analysis was performed to validate the apoptotic findings. Results: The IC50 concentration of SFN was 5.7 µM. The apoptotic assays demonstrated an effective induction of apoptosis in the OECM-1 cells. Western blot analysis demonstrated the dose-dependent upregulation of p53, caspase-3, caspase-9, PARP, cytochrome c, and Bax and the downregulation of the anti-apoptotic proteins Bcl-2 and Smad-4 after SFN treatment. Conclusions: The data obtained indicate that SFN has significant potential to induce apoptosis in OECM-1 cells by disrupting mitochondrial function and modulating apoptotic pathways. The outcomes of our research indicate SFN’s potential as a viable treatment drug for OSCC.
Article
Full-text available
Epigenetic mechanisms control gene expression during normal development and their aberrant regulation may lead to human diseases including cancer. Natural phytochemicals can largely modulate mammalian epigenome through regulation of mechanisms and proteins responsible for chromatin remodeling. Phytochemicals are mainly contained in fruits, seeds, and vegetables as well as in foods supplements. These compounds act as powerful cellular antioxidants and anti-carcinogens agents. Several dietary compounds such as catechins, curcumin, genistein, quercetin and resveratrol, among others, exhibit potent anti-tumor activities through the reversion of epigenetic alterations associated to oncogenes activation and inactivation of tumor suppressor genes. In this review, we summarized the actual knowledge about the role of dietary phytochemicals in the restoration of aberrant epigenetic alterations found in cancer cells with a particular focus on DNA methylation and histone modifications. Furthermore, we discussed the mechanisms by which these natural compounds modulate gene expression at epigenetic level and described their molecular targets in diverse types of cancer. Modulation of epigenetic activities by phytochemicals will allow the discovery of novel biomarkers for cancer prevention, and highlights its potential as an alternative therapeutic approach in cancer.
Article
Full-text available
Sulforaphane (SFN), a compound derived from cruciferous vegetables that has been shown to be safe and nontoxic, with minimal/no side effects, has been extensively studied due to its numerous bioactivities, such as anticancer and antioxidant activities. SFN exerts its anticancer effects by modulating key signaling pathways and genes involved in the induction of apoptosis, cell cycle arrest, and inhibition of angiogenesis. SFN also upregulates a series of cytoprotective genes by activating nuclear factor erythroid-2- (NF-E2-) related factor 2 (Nrf2), a critical transcription factor activated in response to oxidative stress; Nrf2 activation is also involved in the cancer-preventive effects of SFN. Accumulating evidence supports that epigenetic modification is an important factor in carcinogenesis and cancer progression, as epigenetic alterations often contribute to the inhibition of tumor-suppressor genes and the activation of oncogenes, which enables cells to acquire cancer-promoting properties. Studies on the mechanisms underlying the anticancer effects of SFN have shown that SFN can reverse such epigenetic alterations in cancers by targeting DNA methyltransferases (DNMTs), histone deacetyltransferases (HDACs), and noncoding RNAs. Therefore, in this review, we will discuss the anticancer activities of SFN and its mechanisms, with a particular emphasis on epigenetic modifications, including epigenetic reactivation of Nrf2.
Article
Full-text available
Breast cancer is the most common cancer and the second leading cause of cancer death among women. An important risk factor for breast cancer is individual genetic background which is initially generated early in human life; for example, during the processes of embryogenesis and fetal development in utero. Bioactive dietary components such as sulforaphane (SFN), an isothiocyanate from cruciferous vegetables including broccoli sprouts (BSp), cabbage and kale, has been shown to reduce the risk of developing many common cancers through regulation of epigenetic mechanisms. Our study indicates a prenatal/maternal BSp dietary treatment exhibited maximal preventive effects in inhibiting breast cancer development compared to postnatal early-life and adult BSp treatments in two transgenic mouse models that can develop breast cancer. Postnatal early-life BSp treatment starting prior to puberty onset showed protective effects in prevention of breast cancer but was not as effective as the prenatal/maternal BSp treatment. However, adulthood-administered BSp diet did not reduce mammary tumorigenesis. Our results suggest that the prenatal/maternal BSp bioactive natural plant product may impact early embryonic development by regulating global differential gene expression through affecting epigenetic profiles resulting in differential susceptibility to breast cancer later in life. These results suggest that a temporal exposure to epigenetic-modulating dietary components such as cruciferous vegetables could be a key factor for maximizing chemopreventive effects on human breast cancer. This study may lead to translational breast cancer chemopreventive potential by appropriate administration of key dietary components leading to early breast cancer prevention in humans.
Article
Full-text available
Isothiocyanates are naturally occurring small molecules that are formed from glucosinolate precursors of cruciferous vegetables. Many isothiocyanates, both natural and synthetic, display anti-carcinogenic activity because they reduce activation of carcinogens and increase their detoxification. This minireview summarizes the current knowledge on isothiocyanates and focuses on their role as potential anti-cancer agents.
Article
Broccoli sprout extract containing sulforaphane (BSE-SFN) has been shown to inhibit ultraviolet radiation-induced damage and tumor progression in skin. This study evaluated the toxicity and potential effects of oral BSE-SFN at three dosages. Seventeen patients who each had at least 2 atypical nevi and a prior history of melanoma were randomly allocated to 50, 100, or 200 µmol oral BSE-SFN daily for 28 days. Atypical nevi were photographed on days 1 and 28, and plasma and nevus samples were taken on days 1, 2, and 28. Endpoints assessed were safety, plasma and skin sulforaphane levels, gross and histologic changes, immunohistochemistry for phospho-STAT3(Y705), Ki-67, Bcl-2, HMOX1, and TUNEL, plasma cytokine levels, and tissue proteomics. All 17 patients completed 28 days with no dose-limiting toxicities. Plasma sulforaphane levels pooled for days 1, 2, and 28 showed median post-administration increases of 120 ng/mL for 50 µmol, 206 ng/mL for 100 µmol, and 655 ng/mL for 200 µmol. Median skin sulforaphane levels on day 28 were 0.0 ng/g, 3.1 ng/g, and 34.1 ng/g for 50, 100, and 200 µmol, respectively. Plasma levels of pro-inflammatory cytokines decreased from day 1 to 28. The tumor suppressor decorin was increased from day 1 to 28. Oral BSE-SFN is well-tolerated at daily doses up to 200 µmol and achieves dose-dependent levels in plasma and skin. A larger efficacy evaluation of 200 µmol daily for longer intervals is now reasonable to better characterize clinical and biological effects of BSE-SFN as chemoprevention for melanoma.
Article
Little is known about the effects of combinatorial dietary compounds on the regulation of epigenetic mechanisms involved in breast cancer prevention. The human diet consists of a multitude of components, and there is a need to elucidate how certain compounds interact in collaboration. Withaferin A (WA), found in the Indian winter cherry and documented as a DNA methyltransferase (DNMT) inhibitor, and sulforaphane (SFN), a well-known histone deacetylase (HDAC) inhibitor found in cruciferous vegetables, are two epigenetic modifying compounds that have only recently been studied in conjunction. The use of DNMT and HDAC inhibitors to reverse the malignant expression of certain genes in breast cancer has shown considerable promise. Previously, we found that SFN + WA synergistically promote breast cancer cell death. Herein, we determined that these compounds inhibit cell cycle progression from S to G2 phase in MDA-MB-231 and MCF-7 breast cancer. Furthermore, we demonstrate that this unique combination of epigenetic modifying compounds down-regulates the levels of Cyclin D1 and CDK4, and pRB; conversely, the levels of E2F mRNA and tumor suppressor p21 are increased independently of p53. We find these events coincide with an increase in unrestricted histone methylation. We propose SFN + WA-induced breast cancer cell death is attributed, in part, to epigenetic modifications that result in the modulated expression of key genes responsible for the regulation of cancer cell senescence.
Article
Background and Objective: Sulforaphane (SFN) is a potent chemopreventive agent obtained from cruciferous vegetables. A series of trials have demonstrated that SFN can induce cell apoptosis in a variety of tumor cells. However, the actual mechanism underlying how SFN induces apoptotic effects in tumor cells remains unclear. Current study aimed to investigate the effects of SFN on growth and apoptosis of acute leukemia cells and its molecular cascades involving in preventing tumor growth. Materials and Methods: In this study, the cell counting Kit-8 assay was used to investigate the consequences of SFN treatment on proliferation of KG1a and K562 cells to determine the appropriate drug concentration. Furthermore, the apoptosis rate of KG1a and K562 cells was assessed by FACS. The expression of Bax, Bcl-2 and caspase-3 in both cells which were affected by sulforaphane was analyzed by quantitative reverse transcription-polymerase (PCR) and Western-blotting, respectively. Results: SFN could inhibit the proliferation of KG1a and K562 cells in a dose and time dependent manner. The numbers of apoptotic cells in SFN treated groups were more than those in control group. In addition, SFN could also increase protein and mRNA expressions of Bax and caspase-3 in a dose dependent manner, but decrease Bcl-2 expression as compared to control group. Conclusion: This study indicated that SFN inhibited tumor cell proliferation and promoted apoptosis in KG1a and K562 cells through modulation of Bax, Bcl-2 and caspase-3. Current work also shed light on SFN as a promising therapeutic agent for the treatment of leukemia.
Article
Isothiocyanates are naturally occurring small molecules that are formed from glucosinolate precursors of cruciferous vegetables. Many isothiocyanates, both natural and synthetic, display anti-carcinogenic activity because they reduce activation of carcinogens and increase their detoxification. This minireview summarizes the current knowledge on isothiocyanates and focuses on their role as potential anti-cancer agents.